Sitofibrate
Sitofibrate is a Clofibrate derivative. Sitofibrate is aperoxisome proliferator activated receptor-α (PPAR-α) agonist. Sitofibrate is an antihyperlipidemic agent[1].
Product Specifications
CAS Number
55902-94-8
UNSPSC
12352005
Target
PPAR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/sitofibrate.html
Solubility
10 mM in DMSO
Smiles
C[C@@]12[C@]3([H])[C@](CC=C1C[C@H](CC2)OC(C(C)(C)OC4=CC=C(C=C4)Cl)=O)([H])[C@@]5([H])[C@](CC3)([C@@](CC5)([H])[C@H](C)CC[C@@H](CC)C(C)C)C
Molecular Formula
C39H59ClO3
Molecular Weight
611.34
References & Citations
[1]Morton, I.K.M., et al. salbutamol hemisulfate. (1999) . S. In: Concise Dictionary of Pharmacological Agents. Springer, Dordrecht.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PPARα
Explore Other Products
Browse additional items from our catalog
TRNAH5 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
